Decentrally Speaking | Episode 2: The Shifting Roles Of Pharmaceutical Depots Within A Decentralized Trial Environment

In this second episode of the Decentrally Speaking series, we will explore how pharmaceutical depots are evolving their services and operations to support both clinical sites and patients, playing a critical role in decentralized trials (DCTs). The expansion of geographies, procurement of ancillary supplies, and storage of investigational drugs and materials for direct-to-patient or direct-to-site shipments create a complex supply chain that requires meticulous management and control.

Join our Parexel clinical trial supplies and logistics experts as they share their extensive experience to ensure an optimal mix of solutions for conducting decentralized trials. Their insights will benefit sponsors, sites, and patients while navigating a complicated and evolving regulatory landscape.

Featuring:

• Sanjay Vyas, Executive Vice President and Global Strategic Business Unit Head for Clinical Trial Supplies and Logistics
• Laurie McRae, Senior Director, Solutions for Clinical Trial Supplies and Logistics
• Daniel Meyer, Project Manager Leader, Supply and Logistics

Our Decentrally Speaking series engages subject matter experts and thought leaders to expand clinical access for patients through decentralized trials. Join us to explore opportunities for operationalizing DCTs across the industry.